Related Articles
Research
Guggenheim Initiates Avalyn Pharma at Buy With $80 Price Target
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$AVLN
Research
UBS Initiates Coverage on Dave With Buy Rating, $300 Price Target
Dave (DAVE) has an average rating of Buy and mean price target of $336.78, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$DAVE
Research
Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$AVLN